These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 7728390)

  • 1. New therapeutic approaches in autoimmune rheumatic diseases, with special emphasis on rheumatoid arthritis.
    Kalden JR; Manger B
    Br J Rheumatol; 1995 Mar; 34(3):193-6. PubMed ID: 7728390
    [No Abstract]   [Full Text] [Related]  

  • 2. Biologic agents in the treatment of inflammatory rheumatic diseases.
    Kalden JR; Manger B
    Curr Opin Rheumatol; 1998 May; 10(3):174-8. PubMed ID: 9608318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologics in the treatment of skin and rheumatologic diseases.
    Kahlenberg JM; Billi AC; Eyerich K; Gudjonsson JE
    J Allergy Clin Immunol; 2020 Apr; 145(4):1138-1141. PubMed ID: 32112793
    [No Abstract]   [Full Text] [Related]  

  • 4. [New strategies in the immunotherapy of autoimmune diseases].
    Lorenz HM; Geiler T
    Dtsch Med Wochenschr; 2001 Sep; 126(37):1023-8. PubMed ID: 11555778
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-CD4 monoclonal antibody therapy in human autoimmune diseases.
    Schulze-Koops H; Lipsky PE
    Curr Dir Autoimmun; 2000; 2():24-49. PubMed ID: 11791458
    [No Abstract]   [Full Text] [Related]  

  • 6. Apheresis. Biotechnology and the rheumatic diseases.
    Klippel JH
    Arthritis Rheum; 1984 Oct; 27(10):1081-5. PubMed ID: 6333244
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-CD4 antibody treatment of patients with rheumatoid arthritis: I. Effect on clinical course and circulating T cells.
    Herzog C; Walker C; Müller W; Rieber P; Reiter C; Riethmüller G; Wassmer P; Stockinger H; Madic O; Pichler WJ
    J Autoimmun; 1989 Oct; 2(5):627-42. PubMed ID: 2572230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor-targeted immunotherapy.
    Janson RW; Arend WP
    Bull Rheum Dis; 1992; 41(3):6-8. PubMed ID: 1617334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New approaches to treatment in immunology with monoclonal antibodies].
    Rubbert A; Diehl V
    Internist (Berl); 2001 Jun; 42(6):843, 846-53. PubMed ID: 11449631
    [No Abstract]   [Full Text] [Related]  

  • 10. Biologic agents in the treatment of inflammatory rheumatic diseases.
    Kalden JR; Manger B
    Curr Opin Rheumatol; 1995 May; 7(3):191-7. PubMed ID: 7612410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other rheumatic diseases (May 2002).
    Furst DE; Breedveld FC; Kalden JR; Smolen JS; Antoni CE; Bijlsma JW; Burmester GR; Cronstein B; Keystone EC; Kavanaugh A; Klareskog L
    Ann Rheum Dis; 2002 Nov; 61 Suppl 2(Suppl 2):ii2-7. PubMed ID: 12379612
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-CD4 monoclonal antibodies in rheumatoid arthritis.
    Choy EH; Kingsley GH; Panayi GS
    Springer Semin Immunopathol; 1998; 20(1-2):261-73. PubMed ID: 9836381
    [No Abstract]   [Full Text] [Related]  

  • 13. From antilymphocyte serum to therapeutic monoclonal antibodies: first experiences with a chimeric CD4 antibody in the treatment of autoimmune disease.
    Riethmüller G; Rieber EP; Kiefersauer S; Prinz J; van der Lubbe P; Meiser B; Breedveld F; Eisenburg J; Krüger K; Deusch K
    Immunol Rev; 1992 Oct; 129():81-104. PubMed ID: 1464423
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunological evaluation of cytokine and anticytokine immunotherapy in vivo: what have we learnt?
    Jorgensen C; Apparailly F; Sany J
    Ann Rheum Dis; 1999 Mar; 58(3):136-41. PubMed ID: 10364909
    [No Abstract]   [Full Text] [Related]  

  • 15. Expectation bias in rheumatoid arthritis clinical trials. The anti-CD4 monoclonal antibody experience.
    Epstein WV
    Arthritis Rheum; 1996 Nov; 39(11):1773-80. PubMed ID: 8912498
    [No Abstract]   [Full Text] [Related]  

  • 16. Monoclonal antibody therapy of inflammatory rheumatic diseases.
    Breedveld FC; van der Lubbe PA
    Br Med Bull; 1995 Apr; 51(2):493-502. PubMed ID: 7552078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biological therapy in rheumatoid arthritis].
    Abraham Simón J
    Rev Invest Clin; 2001; 53(5):452-9. PubMed ID: 11795111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies to CD4.
    Breedveld FC
    Rheum Dis Clin North Am; 1998 Aug; 24(3):567-78. PubMed ID: 9710887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-CD4 monoclonal antibody (mAb) and anti-idiotypic mAb to anti-CD4 in the therapy of autoimmune diseases.
    Perosa F; Scudeletti M; Imro MA; Dammacco F; Luccarelli G; Indiveri F
    Clin Exp Rheumatol; 1997; 15(2):201-10. PubMed ID: 9196876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the treatment of autoimmune diseases; cellular activity, type-1/type-2 cytokine secretion patterns and their modulation by therapeutic peptides.
    Mouzaki A; Deraos S; Chatzantoni K
    Curr Med Chem; 2005; 12(13):1537-50. PubMed ID: 15974986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.